Abstract | BACKGROUND: Nearly 20% of human cancers worldwide have an infectious etiology with the most prominent examples being hepatitis B and C virus-associated hepatocellular carcinoma and human papilloma virus-associated cervical cancer. There is an urgent need to find new approaches to treatment and prevention of virus-associated cancers. METHODOLOGY/PRINCIPAL FINDINGS: CONCLUSIONS/SIGNIFICANCE: This strategy is fundamentally different from the prior uses of radioimmunotherapy in oncology, which targeted tumor-associated human antigens and promises increased specificity and minimal toxicity of treatment. It also raises an exciting possibility to prevent virus-associated cancers in chronically infected patients by eliminating cells infected with oncogenic viruses before they transform into cancer.
|
Authors | Xing Guo Wang, Ekaterina Revskaya, Ruth A Bryan, Howard D Strickler, Robert D Burk, Arturo Casadevall, Ekaterina Dadachova |
Journal | PloS one
(PLoS One)
Vol. 2
Issue 10
Pg. e1114
(Oct 31 2007)
ISSN: 1932-6203 [Electronic] United States |
PMID | 17971877
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Animals
- Antigens, Viral
(chemistry)
- Carcinoma, Hepatocellular
(virology)
- Cell Line, Tumor
- Female
- Hepatitis
(complications)
- Humans
- Medical Oncology
(methods)
- Mice
- Mice, Nude
- Models, Biological
- Neoplasms
(pathology, virology)
- Papillomaviridae
(metabolism)
- Radioimmunotherapy
(methods)
- Uterine Cervical Neoplasms
(virology)
|